secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001628280-26-003907
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus amends 2018 merger agreement milestone terms with Reich Consulting
---------------------------------------------------------------------------

- First Amendment to Merger Agreement dated September 12, 2018, entered on January 22, 2026.
- Amendment adjusts timing and payment terms for certain milestones under the original deal.
- Exhibit 10.1 filed with limited redactions for non-material, competitively harmful details.
- No financial figures or revised milestone amounts disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000162828026003907/0001628280-26-003907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000162828026003907/supn-20260128.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-003907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer